[go: up one dir, main page]

Hofstra et al., 1998 - Google Patents

Vβ8+ T lymphocytes are essential in the regulation of airway hyperresponsiveness and bronchoalveolar eosinophilia but not in allergen‐specific IgE in a murine …

Hofstra et al., 1998

View PDF
Document ID
17768776508093387914
Author
Hofstra
Ark V
Savelkoul
Cruikshank
Nijkamp
Oosterhout V
Publication year
Publication venue
Clinical & Experimental Allergy

External Links

Snippet

Background There is increasing evidence that in allergic asthma the inflammatory process is regulated by T lymphocytes. In BALB/c mice the majority of ovalbumin responsive T lymphocytes express the Vβ8. 1+ and Vβ8. 2+ T‐cell receptor. Objective We analysed the …
Continue reading at www.academia.edu (PDF) (other versions)

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/21—Interferons [IFN]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application

Similar Documents

Publication Publication Date Title
Hamelmann et al. Allergic airway sensitization induces T cell activation but not airway hyperresponsiveness in B cell-deficient mice
Hofstra et al. Differential effects of endogenous and exogenous interferon-γ on immunoglobulin E, cellular infiltration, and airway responsiveness in a murine model of allergic asthma
Afshar et al. Allergic asthma: a tale of many T cells
Moller et al. Inhibition of IL-12 production by thalidomide.
Böhm et al. IL-10 and regulatory T cells cooperate in allergen-specific immunotherapy to ameliorate allergic asthma
Saito et al. Allergen‐induced murine upper airway inflammation: local and systemic changes in murine experimental allergic rhinitis
Leon Invited review: cytokine regulation of fever: studies using gene knockout mice
Savolainen et al. Sublingual immunotherapy in children modulates allergen‐induced in vitro expression of cytokine mRNA in PBMC
Hessel et al. Development of airway hyperresponsiveness is dependent on interferon-gamma and independent of eosinophil infiltration.
Chikano et al. IL-18 and IL-12 induce intestinal inflammation and fatty liver in mice in an IFN-γ dependent manner
De Bie et al. Modulation of airway hyperresponsiveness and eosinophilia by selective histamine and 5‐HT receptor antagonists in a mouse model of allergic asthma
Lv et al. Airway epithelial TSLP production of TLR2 drives type 2 immunity in allergic airway inflammation
Okiyama et al. Therapeutic effects of interleukin‐6 blockade in a murine model of polymyositis that does not require interleukin‐17A
Hirano et al. Pirfenidone modulates airway responsiveness, inflammation, and remodeling after repeated challenge
Fanucchi et al. Immunostimulatory oligonucleotides attenuate airways remodeling in allergic monkeys
Kierstein et al. Ozone inhalation induces exacerbation of eosinophilic airway inflammation and hyperresponsiveness in allergen‐sensitized mice
Darville et al. Mouse strain-dependent chemokine regulation of the genital tract T helper cell type 1 immune response
Nie et al. Role of TNF‐α in virus‐induced airway hyperresponsiveness and neuronal M2 muscarinic receptor dysfunction
Han et al. Curcumin ameliorates rat experimental autoimmune neuritis
De Bie et al. Exogenous interleukin‐16 inhibits antigen‐induced airway hyper‐reactivity, eosinophilia and Th2‐type cytokine production in mice
Long et al. New developments in non-allergen-specific therapy for the treatment of food allergy
Uzonna et al. Anti‐IL‐4 antibody therapy causes regression of chronic lesions caused by medium‐dose Leishmania major infection in BALB/c mice
Wang et al. Interleukin‐13‐dependent bronchial hyper‐responsiveness following isolated upper‐airway allergen challenge in a murine model of allergic rhinitis and asthma
Wilder et al. Ovalbumin aerosols induce airway hyperreactivity in naive DO11. 10 T cell receptor transgenic mice without pulmonary eosinophilia or OVA-specific antibody
Cui et al. Reversal of allergic airway hyperreactivity after long-term allergen challenge depends on γδ T cells